PerkinElmer, Insightful Science to integrate software with cloud-based data

By The Science Advisory Board staff writers

March 18, 2021 -- PerkinElmer has inked a collaboration with Insightful Science through which it will expand its documentation, workflow, and decision-making Signals informatics platform to expand its offerings in biologics drug discovery.

Under the agreement, PerkinElmer's Signals platform will be combined with Insightful Science's cloud-based SnapGene and Geneious Prime software, both of which help molecular biologists accomplish DNA construct design and molecular cloning. The combined offering will allow users to access and compare data across experiments and instruments, PerkinElmer said.

PerkinElmer adds new chromatography columns to portfolio
PerkinElmer has acquired ES Industries, a producer of liquid chromatography consumables, including highly efficient high-performance liquid chromatography...
PerkinElmer licenses CHO cell line to Trinomab Biotech
PerkinElmer has licensed its Horizon Discovery Chosource Chinese hamster ovary (CHO)-K1GS knockout cell line to Trinomab Biotech in China to produce a...
PerkinElmer debuts test kit to expand GPCR therapies
PerkinElmer has debuted new assay kits to help further G protein-coupled receptor (GPCR) drug discovery.
PerkinElmer unveils LC 300 platform, SimplicityChrom software
PerkinElmer has debuted its LC 300 platform and SimplicityChrom software, a package designed to combine high-performance liquid chromatography and ultrahigh-performance...
PerkinElmer debuts ChemOffice+ Cloud
PerkinElmer has introduced ChemOffice+ Cloud, a new application for its ChemDraw chemistry drawing software portfolio.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter